IL20 and COVID-19: Enrichment of IL-20, IL-2, IL-6, KIT, and JAK-STAT signaling pathways was unique to monocytes and DCs from patients with COVID-19, suggesting that innate immune cells may be much more active and cytotoxic in COVID-19 compared to in HIV-1 (Figure 3F).